CYBR CyberCare the new look of healthcare Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYBR CyberCare the new look of healthcare

CYBR 426.35

-0.7%

9:33 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: StockDung who wrote (2212)	6/19/2000 1:44:00 PM
From: sommovigo	Read Replies (2) of 3392

Floyd, CYBR doesn't seem to be to blame for anything... that's the deal. Instead of issuing a letter to CYBR asking that they stop marketing their equipment in the fashion that they have, they instead approved the equipment. So all of the bellyaching about breaking FDA rules was for naught - the FDA apparently didn't think so after looking into it. That's the real deal - FDA determined not only was CYBR not breaking rules as you and others (including Herb)alleged, they determined that the equipment was good enough to sell. HOWEVER, even though the FDA found nothing wrong with CYBR - that Herb (and his informants) DID seems to indicate wrongdoing hurt the price of CYBR so badly that it wiped out a couple of people on margin. Where is the justice there? Individual investors hurt by the incessant bender that Herb went on against CYBR - and it was all unjustified and prompted by short-selers "informing" Herb Greenberg. It hurt real people that were invested in a real company with real technology that the FDA approved... Herb's journalistic reach caused the stock to dive from $16 because of some unjustified assumptions that were later seen to be meaningless. People were hurt by unjustified bashing and poor reporting that seemed to me to be in concert with synchronized short-selling. When so many shares are short and a reporter unjustifiably attacks a stock - it makes me wonder if there is not questionable collusion, especially in the wake of vindication from the FDA both in the form of no reprimandory letter and 510k approval for the units in question.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next